AxioMx has launched AxioMx Express, a new service featuring rapid, five-week development of affordable custom recombinant antibodies.

Tom Thompson, vice president of sales and marketing at AxioMx, said, “Researchers no longer need to wait four to six months or more to receive a custom antibody as they do with traditional, animal-based development methods. AxioMx’s Express platform can generate custom antibodies to antigens in just over one month, helping our customers attain results and publish faster.”